SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-396717"
 

Search: id:"swepub:oai:DiVA.org:uu-396717" > Lowered anti-beta1 ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome

Ernst, Diana (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
Westerbergh, Johan (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
Sogkas, Georgios (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
show more...
Jablonka, Alexandra (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
Ahrenstorf, Gerrit (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
Schmidt, Reinhold Ernst (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
Heidecke, Harald (author)
CellTrend GmbH, Luckenwalde, Germany
Wallentin, Lars, 1943- (author)
Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)
Riemekasten, Gabriela (author)
Univ Schleswig Holstein, Dept Rheumatol, Lubeck, Germany
Witte, Torsten (author)
Med Sch Hannover, Dept Immunol & Rheumatol, Hannover, Germany
show less...
 (creator_code:org_t)
2019-10-10
2019
English.
In: Scientific Reports. - : NATURE PUBLISHING GROUP. - 2045-2322. ; 9
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Although several risk factors exist for acute coronary syndrome (ACS) no biomarkers for survival or risk of re-infarction have been validated. Previously, reduced serum concentrations of anti-beta(1)AR Ab have been implicated in poorer ACS outcomes. This study further evaluates the prognostic implications of anti-beta(1)AR-Ab levels at the time of ACS onset. Serum anti-beta(1)AR Ab concentrations were measured in randomly selected patients from within the PLATO cohort. Stratification was performed according to ACS event: ST-elevation myocardial infarct (STEMI) vs. non-ST elevation myocardial infarct (NSTEMI). Antibody concentrations at ACS presentation were compared to 12-month all-cause and cardiovascular mortality, as well as 12-month re-infarction. Sub-analysis, stratifying for age and the correlation between antibody concentration and conventional cardiac risk-factors was subsequently performed. Serum anti-beta(1)AR Ab concentrations were measured in 400/799 (50%) STEMI patients and 399 NSTEMI patients. Increasing anti-beta(1)AR Ab concentrations were associated with STEMI (p = 0.001). Across all ACS patients, no associations between anti-beta(1)AR Ab concentration and either all-cause cardiovascular death or myocardial re-infarction (p = 0.14) were evident. However among STEMI patients <60 years with anti-beta(1)AR Ab concentration median (14/198 (7.1%) vs. 2/190 (1.1%)); p = 0.01). Similarly, the same sub-group demonstrated greater risk of cardiovascular death in year 1, including re-infarction and stroke (22/198 (11.1%) vs. 10/190 (5.3%); p = 0.017). ACS Patients <= 60 years, exhibiting lower concentrations of beta(1)AR Ab carry a greater risk for early re-infarction and cardiovascular death. Large, prospective studies quantitatively assessing the prognostic relevance of Anti-beta(1)AR Ab levels should be considered.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view